← Open Payments lookup

KENDALL BUTZ: Open Payments

NPI 1801575543 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,958 in 66 payments from 18 companies in 2025. Trend: 2023 $109 · 2024 $1,224 · 2025 $1,958

Food & beverage: $1,930Consulting: $20Education: $8
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$665
GENZYME CORPORATION9$276
GlaxoSmithKline, LLC.9$198
Regeneron Healthcare Solutions, Inc.5$175
Amgen Inc.5$138
Ionis Pharmaceuticals, Inc.3$108
Grifols USA, LLC3$83
Takeda Pharmaceuticals U.S.A., Inc.2$52
BioCryst US Sales Co., LLC1$37
Optinose US, Inc.1$30

Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, DAWNZERA, AIRSUPRA, Xembify, XOLAIR.

Industry payments across CA — which companies pay providers there.